NCT06576947

Brief Summary

The purpose of the current randomized clinical trial was to compare the effectiveness of virtual reality versus posterior tibial nerve stimulation on the improvement of pelvic floor dysfunctions in women with multiple sclerosis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Sep 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 29, 2024

Status Verified

August 1, 2024

Enrollment Period

10 months

First QC Date

July 25, 2024

Last Update Submit

August 28, 2024

Conditions

Keywords

virtual realitymultiple sclerosispelvic floorrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Pelvic floor strength

    Pelvic floor strength using a perineometer, a device for measuring the strength of the pelvic floor, to which a speculum is adapted. measure force in newtons

    At baseline, immediately after the intervention, and 4 weeks] [Safety Issue: No] It is a device for measuring the strength of the pelvic floor, to which a speculum is adapted. measure force in newtons

Secondary Outcomes (4)

  • Australian pelvic floor questionnaire:

    At baseline, immediately after the intervention, and 4 weeks

  • Multiple Sclerosis Quality of Life-54 (MSQOL-54):

    At baseline, immediately after the intervention, and 4 weeks

  • Euroqol

    At baseline, immediately after the intervention, and 4 weeks

  • SF12

    At baseline, immediately after the intervention, and 4 weeks

Study Arms (3)

Virtual reality therapy

EXPERIMENTAL

It will ve placement of virtual reality glasses that will indicate to the patient when to contract the pelvic floor.

Other: Virtual reality

Neuromodulation of the tibialis posterior

EXPERIMENTAL

Is placed a external electrode 5 centimeters (cm) above the medial malleolus and 1 cm behind of the tibia and another electrode on the medial aspect of the foot, below the malleolus. The kind of electric current used will be rectangular, biphasic, with a pulse duration of 220 Ps and a frequency of 10 Hz. To avoid habituation to the current, a phase of 20 s stimulation with a 4 s rest phase. The intensity of the current will be inframotor, just below the contraction threshold of the flexor digitorum muscle brevis.

Other: Neuromodulation of the tibialis posterior nerve

Pelvic Floor Muscle Training

EXPERIMENTAL

Patients will perform Pelvic Floor Muscle Training. Before performing this treatment at home, a session will be held with an expert physiotherapist in pelvic floor who will explain its implementation to the participants of this group.

Other: Pelvic floor muscle training

Interventions

Participants receive virtual reality treatment, 8 weeks of treatment/ 2 times a week

Virtual reality therapy

Participants receive neuromodulation of the tibialis posterior nerve8 weeks of treatment/ 2 times a week/ 30 minutes

Neuromodulation of the tibialis posterior

Participants receive pelvic floor muscle training 5 times a day for 9 weeks

Pelvic Floor Muscle Training

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of multiple sclerosis
  • Presence of pelvic floor dysfunction
  • Acceptance participation
  • Not undergoing another physical therapy treatment

You may not qualify if:

  • Non-acceptance of participation
  • Mental illness
  • Interruption of adherence to protocolized treatment sessions
  • Indication of surgical treatment in the pelvic floor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Guadalupe Molina Torres

    Universidad de Almeria

    PRINCIPAL INVESTIGATOR
  • Jacobo Ángel Rubio-Arias

    Universidad de Almeria

    PRINCIPAL INVESTIGATOR
  • Marta María Córdoba Peláez

    Universidad de Almeria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single Blind (Subject)
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer

Study Record Dates

First Submitted

July 25, 2024

First Posted

August 29, 2024

Study Start

September 1, 2024

Primary Completion

July 1, 2025

Study Completion

December 1, 2025

Last Updated

August 29, 2024

Record last verified: 2024-08